Maplight Therapeutics, Inc. · NASDAQ:MPLT
Kreitzer Anatol sold 12,248 Maplight Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Kreitzer Anatol (Chief Discovery Officer) sold 12,248 Maplight Therapeutics, Inc. shares at US$7.84 for US$96,024, leaving 168,678 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 12,248 shares
- Price
- US$7.84
- Value
- US$96,024
- Holding after
- 168,678 shares
- Trading plan
- No
- Role
- Chief Discovery Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Voting Common Stock | Sale | 12,248 | US$7.84 | 168,678 | Direct |
Source
Download original · View original at SEC
Related
- Maplight Therapeutics, Inc.
- Kreitzer Anatol
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Kreitzer Anatol · Aug 19, 2026
- Form 4 · Kreitzer Anatol · Jul 20, 2026
- Form 4 · Kreitzer Anatol · Apr 29, 2026
- Form 4 · Kreitzer Anatol · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026